SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-22-290073
Filing Date
2022-11-21
Accepted
2022-11-21 17:26:17
Documents
48
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d328604d10q.htm   iXBRL 10-Q 774957
2 EX-31.1 d328604dex311.htm EX-31.1 10994
3 EX-31.2 d328604dex312.htm EX-31.2 11021
4 EX-32.1 d328604dex321.htm EX-32.1 4557
5 EX-32.2 d328604dex322.htm EX-32.2 4583
  Complete submission text file 0001193125-22-290073.txt   4201960

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ignyu-20221030.xsd EX-101.SCH 39758
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ignyu-20221030_cal.xml EX-101.CAL 20015
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ignyu-20221030_def.xml EX-101.DEF 159816
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ignyu-20221030_lab.xml EX-101.LAB 270830
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ignyu-20221030_pre.xml EX-101.PRE 229858
42 EXTRACTED XBRL INSTANCE DOCUMENT d328604d10q_htm.xml XML 671305
Mailing Address 3350 W BAYSHORE RD. SUITE 100 PALO ALTO CA 94303
Business Address 3350 W BAYSHORE RD. SUITE 100 PALO ALTO CA 94303 (650) 549-9103
Peak Bio, Inc. (Filer) CIK: 0001834645 (see all company filings)

IRS No.: 852448157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39951 | Film No.: 221406798
SIC: 2836 Biological Products, (No Diagnostic Substances)